MYRIAD GENETICS, INC. Foreign Currency Transaction Gain, before Tax
MYRIAD GENETICS, INC. (MYGN) reported Foreign Currency Transaction Gain, before Tax of $500.00 thousand for the 6-month period ending 2014-12-31, per its 10-Q filed 2016-02-03.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionGainBeforeTax · last filed 2016-02-03
- 2014-12-31: Foreign Currency Transaction Gain, before Tax 6 month $500.00K; Foreign Currency Transaction Gain, before Tax 6 month as first filed $535.00K.
| Period end | Foreign Currency Transaction Gain, before Tax 6 month | Foreign Currency Transaction Gain, before Tax 6 month as first filed |
|---|---|---|
| 2014-12-31 | $500.00K 10-Q · filed 2016-02-03 | $535.00K 10-Q · filed 2015-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |